E-cadherin and c-Met expression in actinic cheilits and lip squamous cell carcinoma

Martínez, A.; Spencer, M.L.; Borlando, J.; Flores, M.; Rojas, I.G.

doi:10.1016/S0718-5391(11)70079-9

Información del artículo

Resumen

Bibliografía

Descargar PDF

Estadísticas

Abstract

Objective

The aim of this study was to assess epithelial expression of E-cadherin and c-Met in normal lip, in actinic cheilitis and lip squamous cell carcinoma.

Study Design

Biopsies of normal lip vermillion (NL, n=18), actinic cheilitis (AC, n=37), and lip SCC (n=22) were processed for E-cadherin and c-Met immunodetection. Epithelial and tumor cell expression was scored for each sample considering staining intensity and percentage.

Results

E-cadherin expression was significantly reduced in AC and lip SCC as compared to normal lip (P<0.05), with a significant reduction in lip SCC as compared to AC (P=0.003). Expression of c-Met was significantly higher in AC and lip SCC as compared to NL (P<0.05), with a significant increase in lip SCC as compared to AC (P<0.0001).

Conclusion

The results showed that epithelial E-cadherin expression is reduced and c-Met expression is increased as lip carcinogenesis progresses, suggesting that these proteins may be useful markers of malignant transformation.

Key words:

E-cadherin

c-Met

lip carcinogenesis

UV light

actinic cheilitis

lip squamous cell carcinoma

El Texto completo está disponible en PDF

Referencias bibliográficas

[1.]

J.G. de Visscher, Waa. van der.

Etiology of the cancer of the lip. A review.

Int J Oral Maxillofac Surg, 27 (1998), pp. 199-203

Medline

[2.]

M. Takeichi.

Cadherins: A molecular family important in cell-cell adhesion.

Ann Rev Biochem, 59 (1990), pp. 237-252

http://dx.doi.org/10.1146/annurev.bi.59.070190.001321 | Medline

[3.]

H. Shiozaki, H. Oka, M. Inoue, S. Tamura, M. Monden.

E-cadherin mediated adhesion system in cancer cells.

Cancer, 77 (1996), pp. 1605-1613

http://dx.doi.org/10.1002/(SICI)1097-0142(19960415)77:8<1605::AID-CNCR28>3.0.CO;2-2 | Medline

[4.]

T. Sakaki, I. Tamura, H. Kadota, K. Kakudo.

Changing expression of E- and P- cadherin during the tongue carcinogenesis induced by 4-itroquinoline 1-oxide.

J Oral Pathol Med, 32 (2003), pp. 530-537

Medline

[5.]

A. Santos-Garcia, M.M. Abad-Hernández, E. Fonseca-Sánchez, R. Julián- González, P. Galindo-Villardón, J.J. Cruz-Hernández, A. Bullón-Sopelana.

E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma.

Med Oral Patol Oral Cir Bucal, 11 (2006), pp. E100-E105

Medline

[6.]

S. Brouxhon, S. Kyrkanides, M.K. O’Banion, R. Johnson, D.A. Pearce, G.M. Centola, J.H. Miller, K.H. McGrath, B. Erdle, G. Scott, S. Schneider, J.A. Van Buskirk, A.P. Pentland.

Sequential down-regulation of E-Cadherin with squamous cell carcinoma progression: Loss of E-Cadherin via a prostaglandin E2-EP2–dependent posttranslational mechanism.

Cancer Res, 67 (2007), pp. 7654-7664

http://dx.doi.org/10.1158/0008-5472.CAN-06-4415 | Medline

[7.]

M. Murai, X. Shen, L. Huang, W.M. Carpenter, C.S. Lin, S. Silverman, J. Regezi, R.H. Kramer.

Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.

International Journal of Oncology, 25 (2004), pp. 831-840

Medline

[8.]

S. Koseki, S. Ansai, T. Aoki, Y. Hozumi, Y. Mitsuhashi, S. Kondo.

E-cadherin expression in skin tumors using an AMeX immunohistostaining method.

J Dermat, 27 (2000), pp. 307-311

[9.]

A. Bánkfalvi, M. Krabort, A. Vegh, E. Felszeghy, J. Piffko.

Deranged expression of the E-cadherin/ß -catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas.

J Oral Pathol Med, 31 (2002), pp. 450-457

Medline

[10.]

M. Dinitz-Freitas, T. Garcia-Caballero, J. Antúnez-López, J.M. Gándara-Rey, A. Garcia-Garcia.

Reduced E-cadherin expression as an indicator of unfavorable prognosis in oral squamous cell carcinoma.

Oral Oncol, 42 (2006),

[11.]

K.F. Hung, C.S. Chang, C.J. Liu, M.T. Lui, C.Y. Cheng, S.Y. Kao.

Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma.

Oral Pathol Med, 35 (2006), pp. 589-594

[12.]

M.C. Cruz, A.L. Pereira, F.F. Lopes, C.F. Nonaka, R.R. Silva, A. Freitas Rde, L.B. Souza, L.P. Pinto.

Immunohistochemical expression of E-cadherin and CD44v6 in squamous cell carcinomas of the lower lip and tongue.

Braz Dent J, 20 (2009), pp. 64-69

Medline

[13.]

S.U. Han, H.Y. Lee, J.H. Lee, W.H. Kim, H. Nam, H. Kim, Y.K. Cho, M.W. Kim, K.U. Lee.

Modulation of E-cadherin by hepatocyte growth factor induces aggressiveness of gastric carcinoma.

Ann Surg, 242 (2005), pp. 676-683

Medline

[14.]

Yong-Quan Chu, Zai-Yuan Ye, Hou-Quan Tao, Yuan-Yu Wang, Zhong-Sheng Zhao.

Relationship between cell adhesion molecules expression and the biological behavior of gastric carcinoma.

World J Gastroenterol, 14 (2008), pp. 1990-1996

Medline

[15.]

M. Götte, C. Kersting, I. Radke, L. Kiesel, P. Wülfing.

An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ.

Breast Cancer Res, 9 (2007), pp. 1-12

[16.]

M. Dohadwala, S.C. Yang, J. Luo, S. Sharma, R.K. Batra, M. Huang, Y. Lin, L. Goodglick, K. Krysan, M.C. Fishbein, L. Hong, C. Lai, R.B. Cameron, R.M. Gemmill, H.A. Drabkin, S.M. Dubinett.

Cyclooxygenase-2-dependent regulation of E-cadherin: Prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer.

Cancer Res, 15 (2006), pp. 5338-5345

[17.]

D.S. Rao, D. Gui, M.E. Koski, L.M. Popoviciu, H. Wang, R.E. Reiter, J.W. Said.

An inverse relation between COX-2 and E-cadherin expression correlates with aggressive histologic features in prostate cancer.

Appl Immunohistochem Mol Morphol, 14 (2006), pp. 375-383

http://dx.doi.org/10.1097/01.pai.0000210417.61117.6c | Medline

[18.]

C.H. Kim, J. Kim, H. Kahng, E.C. Choi.

Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.

Ann Surg Oncol, 14 (2007), pp. 1565-1574

http://dx.doi.org/10.1245/s10434-006-9320-5 | Medline

[19.]

W.S. Moon, H.S. Park, H. Lee, R. Pai, A.S. Tarnawski, K.R. Kim, K.Y. Jang.

Co-Expression of COX-2, C-Met and ß-catenin in cells forming invasive of gallbladder cancer.

Cancer Res Treat, 37 (2005), pp. 171-176

http://dx.doi.org/10.4143/crt.2005.37.3.171 | Medline

[20.]

U. Drebber, S.E. Baldus, B. Nolden, G. Grass, E. Bollschweiler, H.P. Dienes, A.H. Hölscher, S.P. Mönig.

The over expression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation.

Oncol Rep, 19 (2008), pp. 1477-1483

Medline

[21.]

J.H. Chen, C.W. Wu, H.L. Kao, H.M. Chang, A.F. Li, T.Y. Liu, C.W. Chi.

Effects of COX-2 inhibitor on growth of human gastric cancer cells and its relation to hepatocyte growth factor.

Cancer Lett, 239 (2006), pp. 263-270

http://dx.doi.org/10.1016/j.canlet.2005.08.026 | Medline

[22.]

Y. Miyata, Y. Sagara, S. Kanda, T. Hayashi, H. Kanetake.

Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: Correlation with matrix metalloproteinase -2 and -7 and E-cadherin.

Hum Pathol, 40 (2009), pp. 496-504

http://dx.doi.org/10.1016/j.humpath.2008.09.011 | Medline

[23.]

Y.S. Chen, J.T. Wang, Y.F. Chang, B.Y. Liu, Y.P. Wang, A. Sun, C.P. Chiang.

Expression of hepatocyte growth factors and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.

J Oral Pathol Med, 33 (2004), pp. 209-217

http://dx.doi.org/10.1111/j.0904-2512.2004.00118.x | Medline

[24.]

S. Scarpino, E. Duranti, A. Stoppacciaro, E. Pilozzi, G. Natoli, S. Sciacchitano, E. Luciani, L. Ruco.

COX-2 is induced by HGF stimulation in Met-positive thyroid papillary carcinoma cells and is involved in tumour invasiveness.

J Pathol, 218 (2009), pp. 487-494

http://dx.doi.org/10.1002/path.2556 | Medline

[25.]

M. Wislez, M.L. Spencer, J.G. Izzo, et al.

Inhibition of mammalian target of rampamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras.

Cancer Res, 65 (2005), pp. 3226-3235

http://dx.doi.org/10.1158/0008-5472.CAN-04-4420 | Medline

[26.]

A. Martínez, U. Brethauer, J. Borlando, M.L. Spencer, I.G. Rojas.

Epithelial expression of p53, mdm-2 and p21 in normal lip and actinic cheilitis.

Oral Oncol, 44 (2008), pp. 878-883

http://dx.doi.org/10.1016/j.oraloncology.2007.11.008 | Medline

[27.]

J.Y. Yang, C.S. Zong, W. Xia, Y. Wei, M.A. Seyed, Zheng Li, K. Broglio, D.A. Berry, M.C.H. Hung.

MDM2 Promotes cell motility and invasiveness by regulating E-cadherin degradation.

Molecular and Cellular Biology, 26 (2006), pp. 7269-7282

http://dx.doi.org/10.1128/MCB.00172-06 | Medline

[28.]

Y.W. Chang, J.W. Marlin, T.W. Chance, R. Jakobi.

RhoA mediates cyclooxygenase-2 signaling to disrupt the formation of adherens junctions and increase cell motility.

Cancer Res, 15 (2006), pp. 11700-11708

[29.]

G.T. Bowden.

Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signaling.

Nat Rev Cancer, 4 (2004), pp. 23-35

http://dx.doi.org/10.1038/nrc1253 | Medline

[30.]

I.G. Rojas, A. Martínez, U. Brethauer, P. Grez, R. Yefi, S. Luza, F.J. Marchesani.

Actinic cheilitis: Epithelial expression of COX-2 and its association with mast cell tryptase and PAR-2.

Oral Oncol, 45 (2009), pp. 284-290

http://dx.doi.org/10.1016/j.oraloncology.2008.05.019 | Medline

[31.]

A. Martínez, U. Brethauer, I.G. Rojas, M. Spencer, F. Mucientes, J. Borlando, M.I. Rudolph.

Expression of apoptotic and cell proliferation regulatory proteins in actinic cheilitis.

J Oral Pathol Med, 34 (2005), pp. 257-262

http://dx.doi.org/10.1111/j.1600-0714.2004.00299.x | Medline

[32.]

D.W. Seol, Q. Chen, M.L. Smith, R. Zarnegar.

Regulation of the c-met proto-oncogen promoter by p53.

The Journal of Biological Chemistry, 274 (1999), pp. 3565-3572

Medline

[33.]

G. Reshetnikova, S. Troyanovsky, D.L. Rimm.

Definition of a direct extracellular interaction between Met and E-cadherin.

Cell Biol Int, 31 (2007), pp. 366-373

http://dx.doi.org/10.1016/j.cellbi.2007.01.022 | Medline

[34.]

K. Shimabukuro, S. Ichinose, R. Koike, T. Kubota, M. Yamaguchi, M. Miyasaka, T. Aso.

Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer.

Gynecol Onco, 83 (2001), pp. 205-215

Indexada en:

Síguenos:

Indexada en:

Síguenos:

Suscríbase a la newsletter